Samorita Hospital Limited (DSE:SAMORITA)

Samorita Hospital Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 10, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	1,544	1,232	1,546	1,478	1,387	1,268
Market Cap Growth	24.87%	-20.31%	4.54%	6.57%	9.38%	10.89%
Enterprise Value	1,491	1,197	1,506	1,466	1,356	1,212
Last Close Price	70.80	56.09	69.74	66.71	62.16	56.14
PE Ratio	83.31	91.04	126.70	2052.27	85.15	30.14
PS Ratio	3.59	3.07	4.09	4.42	4.10	3.22
PB Ratio	1.45	1.17	1.47	1.54	1.43	1.31
P/TBV Ratio	1.45	1.17	1.47	1.54	1.43	1.31
P/FCF Ratio	55.76	75.07	58.00	-	-	-
P/OCF Ratio	32.69	32.88	34.78	55.78	39.65	21.12
EV/Sales Ratio	3.47	2.98	3.98	4.39	4.01	3.08
EV/EBITDA Ratio	28.37	29.27	36.54	54.66	30.64	17.36
EV/EBIT Ratio	52.95	70.83	85.72	387.60	55.57	24.65
EV/FCF Ratio	53.87	72.95	56.51	-	-	-
Debt / Equity Ratio	0.00	0.00	0.02	0.04	0.06	0.06
Debt / EBITDA Ratio	0.08	0.05	0.53	1.49	1.35	0.81
Debt / FCF Ratio	0.15	0.12	0.85	-	-	-
Net Debt / Equity Ratio	-0.05	-0.03	-0.03	0.00	-0.01	-0.05
Net Debt / EBITDA Ratio	-1.01	-0.89	-0.73	-0.08	-0.20	-0.73
Net Debt / FCF Ratio	-1.90	-2.21	-1.13	48.54	0.79	2.35
Asset Turnover	0.35	0.33	0.33	0.30	0.30	0.37
Inventory Turnover	9.27	9.00	8.00	7.10	7.25	8.64
Quick Ratio	1.01	0.83	0.79	0.79	1.10	1.84
Current Ratio	1.62	1.67	1.40	1.48	1.85	2.75
Return on Equity (ROE)	1.75%	1.28%	1.21%	0.07%	1.68%	4.43%
Return on Assets (ROA)	1.44%	0.88%	0.95%	0.21%	1.36%	2.86%
Return on Invested Capital (ROIC)	1.72%	1.24%	1.28%	0.09%	1.74%	4.13%
Return on Capital Employed (ROCE)	2.40%	1.50%	1.50%	0.40%	2.30%	4.60%
Earnings Yield	1.20%	1.10%	0.79%	0.05%	1.17%	3.32%
FCF Yield	1.79%	1.33%	1.72%	-0.00%	-0.81%	-1.70%
Dividend Yield	0.71%	0.89%	0.72%	-	0.70%	1.54%
Payout Ratio	115.89%	80.56%	-	1310.01%	165.70%	-
Total Shareholder Return	0.71%	0.89%	0.72%	-	0.70%	1.54%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.